Before revision:  We propose that fortunellin and its  analogs might be the basis of novel pharmaceuticals  against SARS-CoV-2 induced COVID-19 disease.
After revision:  We propose that fortunellin and its structural analogs might be the basis of novel pharmaceuticals against SARS-CoV-2 induced COVID-19 disease.